Randomized Control Study of Concerta and Strattera on the Improvement of Executive Function in Attention Deficit Hyperactivity Disorder Children.
Phase of Trial: Phase IV
Latest Information Update: 01 May 2016
At a glance
- Drugs Atomoxetine (Primary) ; Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 21 Jul 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 21 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2010 Planned end date changed from 1 Jun 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.